First Look Analyst Calls Briefing for Wednesday, November 16, 2022
Here's a look at early analyst calls for Wednesday.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> BRF SA (BRFS) upgraded to Neutral from Sell at Goldman
> Cabot (CBT) upgraded to Buy from Hold at Deutsche Bank; tgt raised to $90
> Consolidated Water (CWCO) upgraded to Buy from Neutral at Janney; tgt $20
> Lincoln National (LNC) upgraded to Buy from Neutral at Goldman; tgt lowered to $46
> Oscar Health (OSCR) upgraded to Overweight from Equal Weight at Wells Fargo; tgt $4
> Tencent Music (TME) upgraded to Buy from Hold at The Benchmark Company; tgt $7
Downgrades:
> Corteva (CTVA) downgraded to Neutral from Buy at UBS; tgt raised to $73
> DT Midstream (DTM) downgraded to Peer Perform from Outperform at Wolfe Research
> Evoqua Water (AQUA) downgraded to Perform from Outperform at Oppenheimer
> Evotec SE (EVO) downgraded to Hold from Buy at Deutsche Bank
> Magellan Midstream (MMP) downgraded to Underperform from Peer Perform at Wolfe Research; tgt $49
> Rapid7 (RPD) downgraded to Sector Weight from Overweight at KeyBanc Capital Markets
Others:
> AbCellera Biologics (ABCL) initiated with a Buy at Truist; tgt $29
> MindMed (MNMD) initiated with an Outperform at RBC Capital Mkts; tgt $5
Contact [email protected] for any questions or corrections.